<p>美國市場表現強勁，在過去 7 天內上漲了 3.4%，過去一年上漲了 30%，預計未來幾年盈利年增長率將達到 16%。在這樣的環境下，內部持股比例高的成長型公司往往會吸引關注，因為這可能表明公司運營和未來前景方面的強烈信心。</p>
<h3>美國內部持股比例高的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>盈利增長</strong></td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>13%</td>
<td>50.8%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17.2%</td>
<td>53.2%</td>
</tr>
<tr>
<td>GBank Financial Holdings (GBFH)</td>
<td>27.3%</td>
<td>42.2%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>13.2%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>28.4%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>20.6%</td>
<td>97.4%</td>
</tr>
<tr>
<td>AST SpaceMobile (ASTS)</td>
<td>27.9%</td>
<td>109.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.3%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.3%</td>
<td>21.6%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們快速增長的美國內部持股比例高的 205 只股票的完整列表。</p>
<p>下面我們重點介紹幾隻我們獨特篩選器中的最愛。</p>
<h2>Coastal Financial (CCB)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Coastal Financial Corporation，市值為 12.4 億美元，作為 Coastal Community Bank 的銀行控股公司，提供一系列銀行產品和服務，面向華盛頓州普吉特海灣地區的消費者和中小型企業。</p>
<p><strong>運營：</strong> 該公司通過其 CCBX 部門（2.4447 億美元）、社區銀行服務（8696 萬美元）和財務及行政活動（1761 萬美元）產生收入。</p>
<p><strong>內部持股比例：</strong> 13.9%</p>
<p><strong>盈利增長預測：</strong> 年增長 44.2%。</p>
<p>Coastal Financial 有望實現強勁增長，預計盈利年增長率為 44.2%，超過美國市場。收入增長也預計將強勁，年增長率為 36.2%。儘管交易價格低於其估計的公允價值和分析師的目標價格，但最近的內部活動適中。Jeffrey M. Chapman 被任命為董事會成員，增強了其在數字轉型方面的專業知識，可能支持公司在不斷變化的金融環境中未來的戰略舉措。</p>
<ul>
<li>在我們的盈利增長報告中更詳細地瞭解 Coastal Financial 的潛力。</li>
<li>我們編制的估值報告表明，Coastal Financial 當前的價格可能相當適中。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 CCB 盈利和收入增長</p>
<h2>Clover Health Investments (CLOV)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Clover Health Investments, Corp. 在美國提供醫療保險優勢計劃，市值約為 10.1 億美元。</p>
<p><strong>運營：</strong> 該公司的收入主要來自其保險部門，產生了 19.2 億美元的收入。</p>
<p><strong>內部持股比例：</strong> 21.5%</p>
<p><strong>盈利增長預測：</strong> 年增長 77.5%。</p>
<p>Clover Health Investments 通過合作伙伴關係提升其互操作性能力，增強患者數據訪問。儘管最近 CFO 發生了變動，但公司仍專注於增長，預計收入年增長率為 16%，超過市場平均水平。然而，最近的財務數據顯示 2025 年淨虧損為 8555 萬美元，且內部出售情況在三個月內顯著。分析師預測在三年內實現盈利，並可能實現 47.5% 的股價上漲。</p>
<ul>
<li>點擊這裏通過我們的詳細分析未來增長報告發現 Clover Health Investments 的細微差別。</li>
<li>根據我們最近的估值報告，Clover Health Investments 似乎交易價格低於其估計價值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown"/></p>
<p>截至 2026 年 4 月的 CLOV 持股結構</p>
<h2>Warby Parker (WRBY)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Warby Parker Inc. 在美國和加拿大通過實體店和電子商務平台運營眼鏡產品零售，市值約為 26.1 億美元。</p>
<p><strong>運營：</strong> 該公司的收入主要來自整體視覺護理，達 8.7191 億美元。</p>
<p><strong>內部持股比例：</strong> 15.1%</p>
<p><strong>盈利增長預測：</strong> 年增長 61.8%。</p>
<p>Warby Parker 的內部持股比例與其增長軌跡相符，因為公司在 2025 年實現淨收入 164 萬美元，正向盈利轉型。儘管最近有內部出售，分析師預測盈利年增長 61.8%，超過市場平均水平。預計收入年增長率為 16.5%，得益於戰略領導變更和創新，如 AI 眼鏡。該股票交易價格低於公允價值估計，並預計有 39.3% 的潛在價格上漲。</p>
<ul>
<li>點擊探索我們在 Warby Parker 盈利增長報告中的詳細發現。</li>
<li>我們的 Warby Parker 估值報告中的分析暗示，與其估計價值相比，股價被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 WRBY 盈利和收入增長</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>在這裏調查我們完整的 205 家快速增長的美國內部持股比例高的公司的名單。</li>
<li>準備好不同的方法嗎？癌症的終結？這 31 只新興 AI 股票正在開發技術，以便早期識別像癌症和阿爾茨海默病這樣的改變生活的疾病。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和盈利增長率均以年化（每年）增長率的形式引用，時間範圍為 1-3 年。</em></p>
<h3>估值是複雜的，但我們在這裏為您簡化。</h3>
<p>通過我們的詳細分析，發現 Warby Parker 是否被低估或高估，分析內容包括 <strong>公允價值估計、潛在風險、股息、內部交易及其財務狀況。</strong></p>
<p>獲取免費分析</p>

三葉草健康

WRBY

<p>美國市場在過去一週上漲了 3.4%，在過去一年中上漲了 30%，預計年均盈利增長為 16%。擁有高內部持股的公司，如 Coastal Financial、Clover Health 和 Warby Parker，被強調具有強勁的增長潛力。Coastal Financial 預計年均盈利增長為 44.2%，而 Clover Health 儘管近期出現虧損，仍預測增長 77.5%。Warby Parker 預計盈利增長 61.8%，並正在向盈利轉型。這三家公司目前的交易價格均低於其估計的公允價值，顯示出股價上漲的潛力</p>

<p>The United States market has shown robust performance, climbing 3.4% in the last 7 days and rising 30% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, growth companies with high insider ownership often attract attention as they may signal strong confidence from those closest to the business's operations and future prospects.</p>
<div class="lb-trans"><p>美國市場表現強勁，在過去 7 天內上漲了 3.4%，過去一年上漲了 30%，預計未來幾年盈利年增長率將達到 16%。在這樣的環境下，內部持股比例高的成長型公司往往會吸引關注，因為這可能表明公司運營和未來前景方面的強烈信心。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美國內部持股比例高的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>13%</td>
<td>50.8%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17.2%</td>
<td>53.2%</td>
</tr>
<tr>
<td>GBank Financial Holdings (GBFH)</td>
<td>27.3%</td>
<td>42.2%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>13.2%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>28.4%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>20.6%</td>
<td>97.4%</td>
</tr>
<tr>
<td>AST SpaceMobile (ASTS)</td>
<td>27.9%</td>
<td>109.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.3%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.3%</td>
<td>21.6%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>盈利增長</strong></td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>13%</td>
<td>50.8%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17.2%</td>
<td>53.2%</td>
</tr>
<tr>
<td>GBank Financial Holdings (GBFH)</td>
<td>27.3%</td>
<td>42.2%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>13.2%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>28.4%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>20.6%</td>
<td>97.4%</td>
</tr>
<tr>
<td>AST SpaceMobile (ASTS)</td>
<td>27.9%</td>
<td>109.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.3%</td>
<td>29.0%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.3%</td>
<td>21.6%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 205 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們快速增長的美國內部持股比例高的 205 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>下面我們重點介紹幾隻我們獨特篩選器中的最愛。</p>
</div><h2>Coastal Financial (CCB)</h2>
<div class="lb-trans"><h2>Coastal Financial (CCB)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Coastal Financial Corporation, with a market cap of $1.24 billion, operates as the bank holding company for Coastal Community Bank, offering a range of banking products and services to consumers and small to medium-sized businesses in the Puget Sound region of Washington.</p>
<div class="lb-trans"><p><strong>概述：</strong> Coastal Financial Corporation，市值為 12.4 億美元，作為 Coastal Community Bank 的銀行控股公司，提供一系列銀行產品和服務，面向華盛頓州普吉特海灣地區的消費者和中小型企業。</p>
</div><p><strong>Operations:</strong> The company generates revenue through its CCBX segment ($244.47 million), Community Bank services ($86.96 million), and Treasury &amp; Administration activities ($17.61 million).</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司通過其 CCBX 部門（2.4447 億美元）、社區銀行服務（8696 萬美元）和財務及行政活動（1761 萬美元）產生收入。</p>
</div><p><strong>Insider Ownership:</strong> 13.9%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 13.9%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 44.2% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 年增長 44.2%。</p>
</div><p>Coastal Financial is poised for robust growth, with earnings projected to rise 44.2% annually, outpacing the US market. Revenue growth is also expected to be strong at 36.2% per year. Despite trading below its estimated fair value and analyst price targets, insider activity has been moderate recently. The appointment of Jeffrey M. Chapman to the board enhances its expertise in digital transformation, potentially supporting future strategic initiatives as the company navigates evolving financial landscapes.</p>
<div class="lb-trans"><p>Coastal Financial 有望實現強勁增長，預計盈利年增長率為 44.2%，超過美國市場。收入增長也預計將強勁，年增長率為 36.2%。儘管交易價格低於其估計的公允價值和分析師的目標價格，但最近的內部活動適中。Jeffrey M. Chapman 被任命為董事會成員，增強了其在數字轉型方面的專業知識，可能支持公司在不斷變化的金融環境中未來的戰略舉措。</p>
</div><ul>
<li>Take a closer look at Coastal Financial's potential here in our earnings growth report.</li>
<li>The valuation report we've compiled suggests that Coastal Financial's current price could be quite moderate.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的盈利增長報告中更詳細地瞭解 Coastal Financial 的潛力。</li>
<li>我們編制的估值報告表明，Coastal Financial 當前的價格可能相當適中。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth"/></p>
<p>CCB Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 CCB 盈利和收入增長</p>
</div><h2>Clover Health Investments (CLOV)</h2>
<div class="lb-trans"><h2>Clover Health Investments (CLOV)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Clover Health Investments, Corp. offers Medicare Advantage plans in the United States and has a market cap of approximately $1.01 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Clover Health Investments, Corp. 在美國提供醫療保險優勢計劃，市值約為 10.1 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its insurance segment, which generated $1.92 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自其保險部門，產生了 19.2 億美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 21.5%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 21.5%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 77.5% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 年增長 77.5%。</p>
</div><p>Clover Health Investments is advancing its interoperability capabilities through partnerships, enhancing patient data access. Despite a recent CFO transition, the company remains focused on growth with revenue projected to increase by 16% annually, surpassing market averages. However, recent financials show a net loss of US$85.55 million for 2025 and insider selling has been significant over three months. Analysts predict profitability within three years and potential stock price appreciation of 47.5%.</p>
<div class="lb-trans"><p>Clover Health Investments 通過合作伙伴關係提升其互操作性能力，增強患者數據訪問。儘管最近 CFO 發生了變動，但公司仍專注於增長，預計收入年增長率為 16%，超過市場平均水平。然而，最近的財務數據顯示 2025 年淨虧損為 8555 萬美元，且內部出售情況在三個月內顯著。分析師預測在三年內實現盈利，並可能實現 47.5% 的股價上漲。</p>
</div><ul>
<li>Click here to discover the nuances of Clover Health Investments with our detailed analytical future growth report.</li>
<li>In light of our recent valuation report, it seems possible that Clover Health Investments is trading behind its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏通過我們的詳細分析未來增長報告發現 Clover Health Investments 的細微差別。</li>
<li>根據我們最近的估值報告，Clover Health Investments 似乎交易價格低於其估計價值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown"/></p>
<p>CLOV Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 CLOV 持股結構</p>
</div><h2>Warby Parker (WRBY)</h2>
<div class="lb-trans"><h2>Warby Parker (WRBY)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Warby Parker Inc. operates as a retailer of eyewear products through both physical stores and an e-commerce platform in the United States and Canada, with a market cap of approximately $2.61 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Warby Parker Inc. 在美國和加拿大通過實體店和電子商務平台運營眼鏡產品零售，市值約為 26.1 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from Holistic Vision Care, amounting to $871.91 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自整體視覺護理，達 8.7191 億美元。</p>
</div><p><strong>Insider Ownership:</strong> 15.1%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 15.1%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 61.8% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 年增長 61.8%。</p>
</div><p>Warby Parker's insider ownership aligns with its growth trajectory, as the company transitions to profitability with 2025 net income of US$1.64 million. Despite recent insider selling, analysts forecast earnings growth of 61.8% annually, outpacing the market average. Revenue is expected to grow at 16.5% per year, supported by strategic leadership changes and innovation like AI glasses. The stock trades below fair value estimates and anticipates a potential price increase of 39.3%.</p>
<div class="lb-trans"><p>Warby Parker 的內部持股比例與其增長軌跡相符，因為公司在 2025 年實現淨收入 164 萬美元，正向盈利轉型。儘管最近有內部出售，分析師預測盈利年增長 61.8%，超過市場平均水平。預計收入年增長率為 16.5%，得益於戰略領導變更和創新，如 AI 眼鏡。該股票交易價格低於公允價值估計，並預計有 39.3% 的潛在價格上漲。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Warby Parker's earnings growth report.</li>
<li>The analysis detailed in our Warby Parker valuation report hints at an deflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊探索我們在 Warby Parker 盈利增長報告中的詳細發現。</li>
<li>我們的 Warby Parker 估值報告中的分析暗示，與其估計價值相比，股價被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth"/></p>
<p>WRBY Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 WRBY 盈利和收入增長</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Investigate our full lineup of 205 Fast Growing US Companies With High Insider Ownership right here.</li>
<li>Ready For A Different Approach? The end of cancer? These 31 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏調查我們完整的 205 家快速增長的美國內部持股比例高的公司的名單。</li>
<li>準備好不同的方法嗎？癌症的終結？這 31 只新興 AI 股票正在開發技術，以便早期識別像癌症和阿爾茨海默病這樣的改變生活的疾病。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和盈利增長率均以年化（每年）增長率的形式引用，時間範圍為 1-3 年。</em></p>
</div><h3>Valuation is complex, but we're here to simplify it.</h3>
<div class="lb-trans"><h3>估值是複雜的，但我們在這裏為您簡化。</h3>
</div><p>Discover if Warby Parker might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p>
<div class="lb-trans"><p>通過我們的詳細分析，發現 Warby Parker 是否被低估或高估，分析內容包括 <strong>公允價值估計、潛在風險、股息、內部交易及其財務狀況。</strong></p>
</div><p>Access Free Analysis</p>
<div class="lb-trans"><p>獲取免費分析</p>
</div>

Coastal Financial 和另外兩家內部信心強勁的成長型公司